MeiraGTx Holdings plc ã¯ãé節ãªçŸæ£ãæ±ããæ£è
ã®ããã®æ²»çæ³ã®éçºã«æ³šåããŠããèšåºæ®µéã®éºäŒåæ²»çäŒç€Ÿã§ããå瀟ã¯ãéºäŒæ§å€±æãé é žéšããã®æŸå°ç·æ²»çåŸã®å£è
也ç¥çã倿§çŸæ£ãçèçž®æ§åŽçŽ¢ç¡¬åçãªã©ã®ç¥çµå€æ§çŸæ£ãããŒãã³ãœã³ç
ãªã©ã®çŒçŸæ£ã®ããŸããŸãªæ²»çæ³ãéçºããŠããŸããèšåºéçºäžã®ããã°ã©ã ã«ã¯ãè²èŠç°åžžãX æè²äœé£éæ§ç¶²èè²çŽ å€æ§çãRPE65 æ¬ æçãæŸå°ç·èªçºæ§å£è
也ç¥çã®ç¬¬ 1/2 çžèšåºæ®µéããã°ã©ã ãããã³ããŒãã³ãœã³ç
ããã°ã©ã ãå«ãŸããŸããå瀟ã¯ãŸããã·ã§ãŒã°ã¬ã³çå矀ã«é¢é£ããå£è
也ç¥çã®èšåºããã°ã©ã ã®éå§ã«æ³šåããŠãããç¥çµå€æ§çŸæ£ã®åèšåºããã°ã©ã ãæã£ãŠããŸããå瀟ã¯ãç¬èªã®ãªãã¹ã€ããæè¡ã䜿çšããŠå¶åŸ¡å¯èœãªéºäŒåæ²»çãéçºããããã«ãJanssen Pharmaceuticals, Inc. ãšå
±åç ç©¶å¥çŽãçµãã§ããŸããå瀟ã¯2015幎ã«èšç«ããããã¥ãŒãšãŒã¯å·ãã¥ãŒãšãŒã¯ã«æ¬ç€Ÿã眮ããŠããŸãã